Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Cardiology
•
Interventional Cardiology
What is your standard approach (i.e. choice of medication, type of sheath) in the cath lab to reduce the likelihood of radial artery spasm?
Answer from: at Academic Institution
Verapamil and nitroglycerin
Sign in or Register to read more
Answer from: at Community Practice
We use nitro/verapamil and hydrophilic sheath.
Sign in or Register to read more
Answer from: at Community Practice
Ultrasound-guided access, hydrophilic sheath, nitroglycerin, and adequate conscious sedation.
Sign in or Register to read more
Answer from: at Community Practice
So important that the patient is comfortable - needs good verbal interaction and adequate sedation. Hydrophilic sheath, vasodilators, and imaging.
Sign in or Register to read more
Answer from: at Community Practice
Well-informed patient, good sedation, hydrophilic sheath, NTG and Verapamil...
Sign in or Register to read more
20262
21085
21086
21127
21181
Related Questions
What are your top takeaways from ACC 2024?
What is your preferred anticoagulation/antiplatelet regimen for younger patients presenting with ACS, found to have an acute thrombotic event requiring aspiration thrombectomy without need for stent deployment?
What is your approach to using beta-blockers in patients with acute myocardial infarction with preserved LV ejection fraction who undergo early coronary angiography in light of the REDUCE-AMI trial findings?
Following completion of antiplatelet monotherapy (i.e. plavix) plus oral anticoagulation in patients with Afib post-PCI, would you favor continuing antiplatelet therapy + OAC, switching from plavix to aspirin and continuing OAC, or stopping antiplatelet therapy and continuing OAC?
How do you view the balance between opting for percutaneous coronary intervention and prioritizing optimal medical therapy as the initial treatment choice for patients with stable angina?
What is your preferred monotherapy antiplatelet agent to continue after completion of DAPT post-PCI for patients with stable ischemic heart disease?
Do you recommend avoiding radial artery access for cardiac catheterization to preserve potential future dialysis access sites in patients with advanced CKD?
What are alternate approaches to medical therapy and/or interventions to consider in patients with refractory, severe coronary vasospasm despite short-acting nitrates, calcium channel blockers, L-arginine, and clonidine?
Given that high coronary calcium scores portend significantly increased cardiac mortality rates over 5-6 years, is there any data to support performing coronary angiography when the score is very high, e.g. over 1000, even in asymptomatic patients with no objective evidence of ischemia?
What is your approach to correlating stenotic lesions on coronary angiography to magnitude of decline in LV systolic function or cardiomyopathy severity when deciding to intervene or medically manage stable ischemic heart disease as an outpatient?